Atlas Trials

Safety Study of rAAV2/8-hCYP4V2 in Patients With Bietti's Crystalline Dystrophy (BCD)

Clinical trial NCT04722107 · UNKNOWN

Trial details

NCT number
NCT04722107
Sponsor
Beijing Tongren Hospital
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Bietti's Crystalline Dystrophy
Start date
2021-04-21
Primary completion
2024-01-25
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.